Systemic Antibiotic Therapy with Ciprofloxacin or Levofloxacin
For this PEG-site infection with Proteus mirabilis and Pseudomonas aeruginosa, start oral ciprofloxacin 750 mg twice daily or levofloxacin 750 mg once daily for 7-10 days, combined with aggressive local wound care including daily dressing changes and consideration for PEG tube replacement if infection persists despite initial management.
Rationale for Antibiotic Selection
The culture results showing both organisms susceptible to fluoroquinolones makes this the optimal choice because:
- Dual pathogen coverage: Both Proteus mirabilis and Pseudomonas aeruginosa are susceptible to ciprofloxacin and levofloxacin 1
- Oral bioavailability: Fluoroquinolones achieve excellent tissue penetration with oral administration, avoiding need for IV therapy in non-severe cases 2
- Outpatient feasibility: This appears to be a localized soft tissue infection without systemic toxicity (no mention of hypotension, altered mental status, or SIRS criteria), making oral therapy appropriate 3
The IDSA skin and soft tissue infection guidelines support outpatient management for patients without systemic signs of infection 3. Since you've already attempted local wound care and topical antibiotics without success, systemic therapy is now indicated.
Alternative Regimens
If fluoroquinolones are contraindicated or the patient fails initial therapy:
- Piperacillin-tazobactam 3.375-4.5g IV every 6-8 hours 3, 4
- Cefepime 2g IV every 8-12 hours 5
- Meropenem 1g IV every 8 hours (reserve for severe infection) 6
These alternatives would require hospitalization or home IV therapy arrangements. The combination of piperacillin-tazobactam with an aminoglycoside shows synergistic activity against Pseudomonas 7, 8, but this level of aggressive therapy is typically reserved for severe infections with systemic toxicity.
Critical Management Components Beyond Antibiotics
Local Wound Care
- Daily sterile dressing changes with inspection for worsening erythema, purulence, or extension 9
- Antiseptic cleansing of the peristomal area 9
- Ensure external bumper mobility (minimum 5mm free movement) to prevent buried bumper syndrome 9
PEG Tube Assessment
The ESPEN guidelines emphasize that persistent peristomal infection despite appropriate antibiotics may indicate 9:
- Buried bumper syndrome requiring endoscopic evaluation
- Need for tube replacement if infection is refractory
- Possible fistula tract infection requiring tube removal 10
Consider tube replacement if infection persists after 48-72 hours of appropriate antibiotic therapy, as infected long-standing PEG tubes may require removal for source control 10.
Duration and Monitoring
- Treatment duration: 7-10 days for uncomplicated peristomal cellulitis 3
- Clinical response expected: Within 48-72 hours (reduction in erythema, warmth, drainage) 3
- Failure indicators: Worsening erythema >5cm from tube site, fever >38.5°C, or systemic signs warrant hospitalization and IV therapy 3, 4
Common Pitfalls to Avoid
Underestimating Pseudomonas: This organism requires specific anti-pseudomonal coverage; standard cephalosporins like cephalexin are inadequate 5, 11
Inadequate source control: Antibiotics alone may fail if the PEG tube itself is the nidus of infection—don't hesitate to replace the tube if infection persists 10
Premature discontinuation: Complete the full 7-10 day course even if symptoms improve earlier to prevent recurrence 3
Ignoring predisposing factors: Address any underlying issues like excessive tension on the tube, inadequate cleaning technique, or immunosuppression 9
The combination of appropriate systemic antibiotics targeting both organisms plus meticulous local care should resolve this infection. If not improving within 72 hours, escalate to IV therapy and strongly consider infectious disease consultation and tube replacement 3, 10.